TM9SF4 is an F-actin disassembly factor that promotes tumor progression and metastasis

Zhaoyue Meng1,2, Zhichao Li1,3, Mingxu Xie1

  • 1School of Biomedical Sciences and Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Nature Communications
|September 29, 2022
PubMed

Insights

The protein TM9SF4 regulates cancer cell movement and spread by controlling actin dynamics. Its knockdown inhibits tumor growth and metastasis in ovarian cancer models.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Biochemistry

Background:

  • Actin dynamics are essential for cancer cell functions like migration and metastasis.
  • The precise regulatory mechanisms governing actin dynamics remain incompletely understood.

Purpose of the Study:

  • To investigate the role of TM9SF4 in regulating actin dynamics and controlling cancer cell motility and metastasis.

Main Methods:

  • Investigated TM9SF4 function in ovarian cancer cell lines (A2780, SKOV3, HGSOCs).
  • Utilized knockdown experiments to assess effects on cell migration, invasion, tumor growth, and metastasis in vivo.
  • Analyzed F-actin binding and oxidation at Cys374 induced by the TM9SF4 N-terminal fragment (NTF).

Main Results:

  • The TM9SF4 N-terminal fragment (NTF) directly binds F-actin, inducing oxidation at Cys374.
  • This oxidation enhances cofilin-mediated F-actin disassembly.
  • TM9SF4 knockdown significantly reduced migration and invasion in ovarian cancer cells.
  • In vivo, TM9SF4 knockdown completely inhibited tumor growth and metastasis in mice.

Conclusions:

  • TM9SF4 plays a critical role in regulating actin dynamics, thereby controlling ovarian cancer cell motility and metastasis.
  • The findings provide mechanistic insights into TM9SF4's function in cancer progression.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K